Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-29

Clinical Trial Update: False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_FRA) [NA]

View source ↗

Summary

First-in-human study evaluating a shape memory polymer to treat the false lumen and prevent aortic growth in aortic dissection; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Shape Memory Polymer (shape memory polymer)

Snippet

Sponsor: Shape Memory Medical, Inc. | Conditions: Aortic Dissection | NA | Status: NOT_YET_RECRUITING